Synthesis of bioactive 131 I-labeled epidermal growth factor and its distribution in rat tissues.

Radioactive monoiodotyrosyl epidermal growth factor has been synthesized and purified by means of preparative gel electrophoresis. The labeled product retains full biological activity, as compared to that of the native epidermal growth factor. In more extensively iodinated derivatives the biological activity decreases as a function of the degree of iodination. The purified 131I-labeled epidermal growth factor has been injected intraperitoneally in the rat and its distribution in some peripheral tissues such as liver, spleen, cornea, lung, heart, epidermis, skeletal muscle, kidney, brain, pancreas, intestine and testis, followed as a function of time. Only two tissues concentrate 131I-labeled epidermal growth factor with respect to the blood: the epidermis (about + 300%) and the epithelial cells of the cornea (about + 800%). The addition in vitro of native epidermal growth factor is able either to inhibit the binding of the labeled growth factor to the target tissues, or to discharge it after binding in a way which suggests a competition for the specific receptor sites.

[1]  J Roth,et al.  Insulin receptors in the liver: specific binding of ( 125 I)insulin to the plasma membrane and its relation to insulin bioactivity. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[2]  H. Edelhoch,et al.  Spectrophotometric determination of monoiodotyrosine, diiodotyrosine, and thyroxine in iodoproteins. , 1971, Analytical biochemistry.

[3]  P. Cuatrecasas.  Insulin--receptor interactions in adipose tissue cells: direct measurement and properties. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D. Neville,et al.  Monoiodoinsulin: demonstration of its biological activity and binding to fat cells and liver membranes. , 1971, Biochemical and biophysical research communications.

[5]  L. Birnbaumer,et al.  The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. 3. Binding of glucagon: method of assay and specificity. , 1971, The Journal of biological chemistry.

[6]  J. Taylor,et al.  Epidermal growth factor: high and low molecular weight forms. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[7]  G. Marinetti,et al.  Hormone action at the membrane level. II. The binding of epinephrine and glucagon to the rat liver plasma membrane. , 1970, Biochimica et biophysica acta.

[8]  J. Tepperman,et al.  Effect of ethyl p-chlorophenoxyisobutyrate on rat adipose lipoprotein lipase activity. , 1970, The American journal of physiology.

[9]  I. Pastan,et al.  ACTH receptors in the adrenal: specific binding of ACTH-125I and its relation to adenyl cyclase. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. W. Turkington.  The role of epithelial growth factor in mammary gland development in vitro. , 1969, Experimental cell research.

[11]  R. W. Turkington.  Stimulation of mammary carcinoma cell proliferation by epithelial growth factor in vitro. , 1969, Cancer research.

[12]  R. O. Jones.  The in vitro effect of epithelial growth factor on rat organ cultures. , 1966, Experimental cell research.

[13]  J. Wolff,et al.  Iodination of the normal and buried tyrosyl residues of lysozyme. I. Chromatographic analysis. , 1966, Biochemistry.

[14]  S. Cohen,et al.  [Action of the "epidermal growth factor" on nucleic acid and protein synthesis in cutaneous epithelium]. , 1964, Experientia.

[15]  H. Edelhoch.  The Properties of Thyroglobulin VIII. THE IODINATION OF THYROGLOBULIN , 1962 .

[16]  S. Cohen,et al.  Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. , 1962, The Journal of biological chemistry.